Lung
-
Review Meta Analysis
Safety and efficacy of 12-week or longer indacaterol treatment in moderate-to-severe COPD patients: a systematic review.
This is a meta-analysis of the safety and efficacy of indacaterol in chronic obstructive pulmonary disease (COPD) with treatment duration of ≥12 weeks. ⋯ Indacaterol is effective and well-tolerated as a bronchodilator for the maintenance of moderate to severe COPD.